These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 4522064

  • 1. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Clinical observations on adverse reactions.
    Girling DJ.
    Scand J Respir Dis Suppl; 1973; 84():119-24. PubMed ID: 4522064
    [No Abstract] [Full Text] [Related]

  • 2. Clinical aspects of side effects on intermittent rifampicin regimen.
    Zierski M.
    Scand J Respir Dis Suppl; 1973; 84():166-73. PubMed ID: 4522072
    [No Abstract] [Full Text] [Related]

  • 3. Investigations of allergic status and blood counts in Chinese patients receiving daily or intermittent rifampicin in Hong Kong.
    Clin Allergy; 1975 Jun; 5(2):189-99. PubMed ID: 1095248
    [Abstract] [Full Text] [Related]

  • 4. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Correlation between the presence of rifampicin-dependent antibodies and the clinical data.
    Worlledge S.
    Scand J Respir Dis Suppl; 1973 Jun; 84():125-8. PubMed ID: 4522065
    [No Abstract] [Full Text] [Related]

  • 5. Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report.
    Guerra Sanz FJ.
    Scand J Respir Dis Suppl; 1973 Jun; 84():160-5. PubMed ID: 4522071
    [No Abstract] [Full Text] [Related]

  • 6. A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy. A Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation.
    Clin Allergy; 1974 Mar; 4(1):1-12. PubMed ID: 4824569
    [No Abstract] [Full Text] [Related]

  • 7. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. The detection of rifampicin-dependent antibodies.
    Worlledge S.
    Scand J Respir Dis Suppl; 1973 Mar; 84():60-3. PubMed ID: 4544603
    [No Abstract] [Full Text] [Related]

  • 8. The intermittent chemotherapy of tuberculosis with rifampicin regimens on ambulatory basis.
    Anastasatu C, Bungeteanu G, Sibila S.
    Scand J Respir Dis Suppl; 1973 Mar; 84():136-9. PubMed ID: 4522068
    [No Abstract] [Full Text] [Related]

  • 9. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Observations on antibody reaction scores on individual patients.
    O'Mahony MG.
    Scand J Respir Dis Suppl; 1973 Mar; 84():64-72. PubMed ID: 4522079
    [No Abstract] [Full Text] [Related]

  • 10. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
    Girling DJ.
    Bull Int Union Tuberc; 1974 Mar; 49(1):451-5. PubMed ID: 4619567
    [No Abstract] [Full Text] [Related]

  • 11. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
    Nitti V.
    Scand J Respir Dis Suppl; 1973 Mar; 84():180-5. PubMed ID: 4593266
    [No Abstract] [Full Text] [Related]

  • 12. Intermittent rifampicin treatment of tuberculosis.
    Riska N, Mattson K.
    Scand J Respir Dis Suppl; 1973 Mar; 84():140-4. PubMed ID: 4522069
    [No Abstract] [Full Text] [Related]

  • 13. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council Investigation.
    Tubercle; 1974 Mar; 55(1):1-27. PubMed ID: 4620294
    [No Abstract] [Full Text] [Related]

  • 14. Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong.
    Aquinas M, Allan WG, Horsfall PA, Jenkins PK, Hung-Yan W, Girling D, Tall R, Fox W.
    Br Med J; 1972 Mar 25; 1(5803):765-71. PubMed ID: 4259217
    [Abstract] [Full Text] [Related]

  • 15. Side effects observed during intermittent rifampicin therapy.
    Stradling P.
    Scand J Respir Dis Suppl; 1973 Mar 25; 84():129-31. PubMed ID: 4522066
    [No Abstract] [Full Text] [Related]

  • 16. A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council investigation.
    Tubercle; 1974 Mar 25; 55(1):1-27. PubMed ID: 4283482
    [No Abstract] [Full Text] [Related]

  • 17. Daily and intermittent short-course regimens in the original treatment of pulmonary tuberculosis. Preliminary results. Cooperative comparative clinical study in Poland.
    Zierski M.
    Scand J Respir Dis Suppl; 1978 Mar 25; 102():48-52. PubMed ID: 278215
    [No Abstract] [Full Text] [Related]

  • 18. Therapeutic effects and side effects of rifampicin administered daily or twice-weekly.
    Gomi J, Aoyagi T.
    Scand J Respir Dis Suppl; 1973 Mar 25; 84():145-52. PubMed ID: 4522070
    [No Abstract] [Full Text] [Related]

  • 19. A trial of intermittent rifampicin and ethambutol in retreatment regimens.
    Zierski M.
    Scand J Respir Dis Suppl; 1973 Mar 25; 84():132-5. PubMed ID: 4522067
    [No Abstract] [Full Text] [Related]

  • 20. [Controlled trial of 6 to 8 month chemotherapeutic regimens in the treatment of pulmonary tuberculosis. A study of Hong Kong Chest Service/British Medical Research Council/].
    Aquinas M.
    Bull Int Union Tuberc; 1978 Dec 25; 53(4):253. PubMed ID: 387136
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.